{
  "timestamp": "2025-04-19 15:24:24",
  "phase": "Tournament Matchup",
  "round": null,
  "elo_score": 1500.6886749178966,
  "content": "Tournament Matchup vs Idea 20\n\nOpponent: Personalized neoantigen vaccines administered post-resection in early-stage cancer will prevent recurrence by enhancing anti-tumor immunity [Artandi 2010]; [McGranahan 2016]; [Chabanon 2021].  \n*New support:* [Ott 2020, Nature].\n\n---\n\nScores by Criterion:\nPlausibility: 7.0 vs 8.0\nNovelty: 8.0 vs 6.0\nCorrectness: 7.0 vs 8.0\nMethodological Rigor: 8.0 vs 7.0\nResource Efficiency: 6.0 vs 5.0\nPotential Impact: 8.0 vs 8.0\nInterdisciplinary Potential: 8.0 vs 7.0\nScalability: 7.0 vs 5.0\n\nVector-based score: 0.519\nELO update: 1500.3 â†’ 1500.7 (+0.4)"
}